BRIEF-Inspira Technologies Oxy BHN Plans FDA Submission For Hyla Blood Sensor In H2 2025

Reuters
04 Mar
BRIEF-Inspira Technologies Oxy BHN Plans FDA Submission For Hyla Blood Sensor In H2 2025

March 4 (Reuters) - Inspira Technologies Oxy BHN Ltd IINN.O:

  • INSPIRA TECHNOLOGIES OXY BHN LTD - PLANS FDA SUBMISSION FOR HYLA BLOOD SENSOR IN H2 2025

  • INSPIRA TECHNOLOGIES OXY BHN LTD - ANNOUNCES 96% ACCURACY IN HYLA BLOOD SENSOR STUDY

Source text: ID:nPn8ZgLtma

Further company coverage: IINN.O

(Reuters.Briefs@thomsonreuters.com)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10